[Effect of moxibustion on SIRT1/eNOS signaling pathway in ApoE-/- atherosclerotic mice]

Xian-Ming Wu1,2, Ning Zhang3, Zhou Zhu3

  • 1The Second Clinical Medical College, Guizhou University of Traditional Chinese Medicine, Guiyang 550025, China.

Abstract

Insights

Moxibustion treatment improved endothelial function and reduced vascular injury in atherosclerosis (AS) mice. This may be linked to its role in regulating the silent information regulator 1 (SIRT1)/endothelial nitric oxide synthase (eNOS) pathway.

Area of Science:

  • Cardiovascular Research
  • Integrative Medicine
  • Molecular Biology

Context:

  • Atherosclerosis (AS) is a chronic inflammatory disease characterized by vascular endothelial dysfunction.
  • Apolipoprotein E knockout (ApoE-/-) mice are a common model for studying AS.
  • Traditional Chinese Medicine, including moxibustion, is explored for its therapeutic potential in cardiovascular diseases.

Purpose:

  • To investigate the effects of moxibustion on the pathological and ultrastructural changes of the thoracic aorta in ApoE-/- mice with AS.
  • To examine the expression of silent information regulator 1 (SIRT1) and endothelial nitric oxide synthase (eNOS) in response to moxibustion.
  • To elucidate the potential mechanism of moxibustion in preventing and treating AS.

Summary:

  • Moxibustion treatment in ApoE-/- mice significantly increased serum nitric oxide (NO) levels and decreased endothelin-1 (ET-1) levels compared to the model group.
  • Histological and ultrastructural analyses showed reduced thoracic aorta damage and improved endothelial cell morphology following moxibustion.
  • Moxibustion upregulated the expression of endomucin, SIRT1, and eNOS in the thoracic aorta, suggesting enhanced endothelial repair and function.

Impact:

  • Moxibustion demonstrates a protective effect against vascular endothelial injury in an AS mouse model.
  • The findings suggest that moxibustion may improve endothelial function and promote repair through the SIRT1/eNOS signaling pathway.
  • This study provides a potential therapeutic strategy for AS using moxibustion, highlighting its relevance in integrative cardiovascular medicine.

Related Concept Videos

NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
Regulation of the Unfolded Protein Response01:31

Regulation of the Unfolded Protein Response

Inositol-requiring kinase one or IRE1 is the most conserved eukaryotic unfolded protein response (UPR) receptor. It is a type I transmembrane protein kinase receptor with a distinctive site-specific RNase activity. As the binding mechanics of the misfolded proteins with the N-terminal domain of IRE-1 are unclear, three binding models — direct, indirect, and allosteric -- are proposed for receptor activation. Nevertheless, it is known that once a misfolded protein associates with IRE1, it...
Nitric Oxide Signaling Pathway01:28

Nitric Oxide Signaling Pathway

Nitric oxide (NO), an inorganic gas, acts as a potent second messenger in most animal and plant tissues. NO diffuses out of the cells that produce it and enters the neighboring cells to generate a downstream response. NO synthase (NOS) catalyzes NO production by the deamination of the amino acid arginine. There are three isoforms of NOS. Endothelial cells have endothelial NOS (eNOS), nerve and muscle cells have neuronal NOS (nNOS), and macrophages produce inducible NOS (iNOS) upon exposure to...